Idiopathic Pulmonary Fibrosis Cohort of TCM

This study, based on past registration records, evaluates the clinical efficacy of traditional Chinese medicine in treating IPF in the real world, identifies advantageous populations and clinical targets, and provides references for precision traditional Chinese medicine treatment.

NCT Number	NCT07162870
Lead Sponsor	Henan University of Traditional Chinese Medicine Collaborators: The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China-Japan Friendship Hospital, The First Affiliated Hospital of Zhengzhou University, Shanghai Pulmonary Hospital, Shanghai, China
Conditions	Idiopathic Pulmonary Fibrosis (IPF)
Enrollment	1,000 participants
Start Date	2025-09-05
Primary Completion	2028-10-30 (estimated)
Study Completion	2028-11-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-09